Courses

The conference will bring together key stakeholders to analyse the current EU pharmaceutical legislative framework, ongoing regulatory reforms, and the broader policy landscape shaping the sector. Beyond these reforms, the event will also explore complementary initiatives such as the Critical Medicines Act, designed to strengthen supply chains and prevent shortages, as well as targeted measures to combat antimicrobial resistance, one of the most pressing global health threats. Additionally, the conference will highlight the EU’s push to boost biotechnology and biomanufacturing, recognising their role in fostering innovation and enhancing Europe’s strategic autonomy in life sciences.